New Immunomodulatory Therapeutic Vaccine that Targets Oligomeric Amyloid-β Could be Step Towards Halting Alzheimer’s Disease Progression
October 27, 2020 06:56 ET
|
Alzamend Neuro, Inc.
TAMPA, Fla., Oct. 27, 2020 (GLOBE NEWSWIRE) -- Alzheimer’s disease affects more than 5.8 million Americans at an estimated cost at over $305 billion in 2020 according to the Alzheimer's Association....
India Globalization Capital’s CEO to Speak at CEO Healthcare Symposium in NY on February 12 & 13
February 12, 2018 08:00 ET
|
ram mukunda
BETHESDA, Md., Feb. 12, 2018 (GLOBE NEWSWIRE) --
India Globalization Capital, Inc. (NYSE-MKT:IGC) announced today that Ram Mukunda will be a speaker at the upcoming CEO Healthcare Symposium...
IGC Announces Adjournment of Annual Meeting Voting for Proposals Three and Four to Dec 29, 2017
December 18, 2017 08:00 ET
|
India Globalization Capital
BETHESDA, Md., Dec. 18, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC), adjourned again the voting for Proposals Three and Four from its Notice of Annual Meeting of...
IGC Announces Results of Annual Shareholders Meeting
November 13, 2017 14:22 ET
|
India Globalization Capital
BETHESDA, Md., Nov. 13, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC), announced that during its 2016-2017 Annual Meeting of Shareholders scheduled for, and convened...
IGC-AD1 Targeting Alzheimer’s Disease to be commercialized in early 2018 Through Medical Dispensaries
October 18, 2017 08:00 ET
|
India Globalization Capital
BETHESDA, Md., Oct. 18, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) provides compelling in vitro data compiled from genetically engineered cell lines within an...
NYSE American Extends India Globalization Capital Compliance Plan Period
October 12, 2017 14:59 ET
|
India Globalization Capital
BETHESDA, Md., Oct. 12, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital Inc. (NYSE American:IGC) announces that on October 11, 2017 it received notice from NYSE American LLC (“the Exchange”)...
IGC Prepares a Liquid Delivery Formulation of IGC-AD1 for Alzheimer’s Based on Novel In Vitro Data
October 04, 2017 08:00 ET
|
India Globalization Capital
BETHESDA, Md., Oct. 04, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) provides an update on compelling in vitro data compiled from genetically engineered cell lines...
IGC Readies Line of Medical Dispensary Products Targeting Alzheimer’s Disease Based on Novel Data
September 18, 2017 08:00 ET
|
India Globalization Capital
BETHESDA, Md., Sept. 18, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) provides an update on compelling in vitro data compiled from genetically engineered cell lines...
IGC’s Drug Candidate for Alzheimer’s Potentially Presents New Molecular Pathway for THC to Inhibit Aβ40 Production
September 11, 2017 08:00 ET
|
India Globalization Capital
BETHESDA, Md., Sept. 11, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) today provides an update on compelling in vitro data compiled from genetically engineered cell...
IGC Announces Financial Results for Quarter Ended June 30, 2017
August 21, 2017 07:00 ET
|
India Globalization Capital
BETHESDA, Md., Aug. 21, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE AMERICAN:IGC) announces financial results for the quarter ended June 30, 2017. “During the quarter, we...